Use of Human Papillomavirus Type 6 Capsid Protein L1 to Detect Specific Antibodies in Patients with Condyloma Acuminata

TANG Xu,ZHANG Jin,LI Yuan-hong,ZHOU Wei,ZHAO Yu-ming,DONG Xiao-ping,CHEN Hong-Duo
DOI: https://doi.org/10.3321/j.issn:1000-8721.2005.05.007
2005-01-01
Abstract:To produce human papillomavirus (HPV) type 6 major capsid protein (L1) for screening the sera of condyloma acuminata (CA) patients, HPV 6 L1 protein was produced by recombinant baculovirus expression system and purified with affinity chromatography and was used as antigen to analyse by ELISA the sera of 30 CA patients, 20 blood donors and 10 children for the presence of IgG antibody. SDS-PAGE and Western blot showed recombinant baculovirus system could efficiently express HPV 6 L1 protein with good immunoreactivity.IgG antibody to HPV6 L1 protein was detected in sera from 20 of 30 (66.7%) CA patients and 3 of 20 (15%) blood donors (P0.05). Among 30 cases of CA, 15 of 22 (68.2%) CA with HPV6 DNA, 4 of 6 (66.7%) CA with HPV11 DNA, one case of HPV6 and HPV11 co-infection were seropositive to HPV6 L1; the last case with HPV16 DNA, was HPV6 L1 IgG negative. CA male cases were less likely to be seropositive than female cases (P=0.0052). Using recombinant baculovirus expression system, the established ELISA for detection of antibody to HPV6 L1 protein is sensitive and specific for low risk HPV infection, and may be of value for not only sero-epidemiological investigation, but also clinical diagnosis.
What problem does this paper attempt to address?